Crizotinib

⇄

leucine rich repeat kinase 2 ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34285770 Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor. 2021 2